| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |